Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Kabi Stretches Adalimumab Presence To Nine Countries
Four Further Country Launches During Third Quarter
Oct 31 2019
•
By
Aidan Fry
Kabi's Idacio adalimumab biosimilar is now available in nine European countries • Source: Shutterstock
More from Biosimilars
More from Products